Henn Matthew R sold MCRB
November 15, 2025 · Form 4 insider transaction
Henn Matthew R sold 1,257 shares of Seres Therapeutics, Inc. at $17.30 per share, a transaction worth $21.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,257
Price
$17.30
Total value
$21.7K
InsiderHenn Matthew R
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 15, 2025
Filing dateNovember 18, 2025
Shares owned after7,527
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 instruction adopted by the reporting person on April 13, 2023, solely with the intent to cover taxes in connection with the vesting of the restricted stock units.